FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Bilezikian

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Anatomy

Bone and Bones

Procedures

Physiology

Bone Remodeling

Co-author Network

Publications

TOP 3
Juraj Payer; Afrodite Zendeli; John P Bilezikian; Gerold Holzer; Péter Lakatos; Olga Lesnyak; Roman Lorenc; Heinrich Resch
Congress Report: 5th Central and Eastern Europe (CEE) Summit on Osteoporosis in Bratislava, 2-3 December 2011.
Thuy D T Vu; Qingju Wang; Xiao Fang Wang; Roger Martin Djoumessi Zebaze; Barbara C Silva; Julia Udesky; John P Bilezikian; Stephanie Boutroy; Natalie E Cusano; Ali Ghasem-Zadeh; Dinaz Irani; George Jerums; Megan E Romano; Ego Seeman
New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone.
Emily M Stein; Julia Udesky; Ji Wang; Chiyuan Zhang; Bin Zhou; Stephanie Boutroy; Aline G Costa; Serge Cremers; Natalie Cusano; Elzbieta Dworakowski; X Edward Guo; Dinaz Irani; Donald J McMahon; Megan Romano; Elizabeth Shane; Barbara C Silva; John P Bilezikian
Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Bilezikian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Juraj Payer; Afrodite Zendeli; John P Bilezikian; Gerold Holzer; Péter Lakatos; Olga Lesnyak; Roman Lorenc; Heinrich Resch
Congress Report: 5th Central and Eastern Europe (CEE) Summit on Osteoporosis in Bratislava, 2-3 December 2011.
Archives of osteoporosis 2013;8(1-2):123.
2013: Thuy D T Vu; Qingju Wang; Xiao Fang Wang; Roger Martin Djoumessi Zebaze; Barbara C Silva; Julia Udesky; John P Bilezikian; Stephanie Boutroy; Natalie E Cusano; Ali Ghasem-Zadeh; Dinaz Irani; George Jerums; Megan E Romano; Ego Seeman
New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone.
Bone 2013;55(1):57-63.
2013: Emily M Stein; Julia Udesky; Ji Wang; Chiyuan Zhang; Bin Zhou; Stephanie Boutroy; Aline G Costa; Serge Cremers; Natalie Cusano; Elzbieta Dworakowski; X Edward Guo; Dinaz Irani; Donald J McMahon; Megan Romano; Elizabeth Shane; Barbara C Silva; John P Bilezikian
Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013;28(5):1029-40.
2013: John P Bilezikian; Alexander R Cobitz; Richard Eastell; Robert G Josse; Barbara G Kravitz; E Michael Lewiecki; Colin G Miller; Antonio J Nino; Allison R Northcutt; Gitanjali Paul; Margaret Wooddell; Lorraine A Fitzpatrick
Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus.
The Journal of clinical endocrinology and metabolism 2013;98(4):1519-28.
2013: Dennis M Black; H G Bone; Susan L Greenspan; H S Andersen; John P Bilezikian; M Muñoz-Torres; C J Rosen; C Wüster; David A Hanley
Improved adherence with PTH(1-84) in an extension trial for 24 months results in enhanced BMD gains in the treatment of postmenopausal women with osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2013;24(4):1503-11.
2013: João Lindolfo C Borges; Anderson Freitas; John P Bilezikian
Accelerated fracture healing with teriparatide.
Arquivos brasileiros de endocrinologia e metabologia 2013;57(2):153-6.
2013: Natalie E Cusano; Shonni J Silverberg; John P Bilezikian
Normocalcemic primary hyperparathyroidism.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2013;16(1):33-9.
2013: Aline G Costa; John P Bilezikian
Bone turnover markers in primary hyperparathyroidism.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2013;16(1):22-7.
2013: Shonni J Silverberg; Marcella D Walker; John P Bilezikian
Asymptomatic primary hyperparathyroidism.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2013;16(1):14-21.
2013: Aliya A Khan; John T Potts; Maria Luisa Brandi; John P Bilezikian
Supplement on primary hyperparathyroidism.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2013;16(1):3.
2013: Natalie E Cusano; Rebecca Ives; Donald J McMahon; Mishaela R Rubin; James Sliney; Amanda Tulley; Chiyuan Zhang; Serge C Cremers; John P Bilezikian
Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.
The Journal of clinical endocrinology and metabolism 2013;98(1):137-44.
2012: Cristiana Cipriani; Cristiana Capriani; Dinaz Irani; John P Bilezikian
Safety of osteoanabolic therapy: a decade of experience.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(12):2419-28.
2012: M D Walker; T Lang; G Liu; Donald J McMahon; I Saeed; J Udesky; John P Bilezikian
Volumetric bone mineral density at the spine and hip in Chinese American and White women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012;23(10):2499-506.
2012: Patrik Christen; David W Dempster; Keita Ito; Ralph Müller; Mishaela R Rubin; John P Bilezikian; Bert Van Rietbergen
Patient-specific bone modelling and remodelling simulation of hypoparathyroidism based on human iliac crest biopsies.
Journal of biomechanics 2012;45(14):2411-6.
2012: John P Bilezikian
Primary hyperparathyroidism.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2012;18(5):781-90.
2012: Natalie E Cusano; John P Bilezikian
Combination anabolic and antiresorptive therapy for osteoporosis.
Endocrinology and metabolism clinics of North America 2012;41(3):643-54.
2012: Yan Jiang; Jin Jin; Hong-li Jing; Fang Li; Mei Li; John P Bilezikian; Peng Gao; Fang Qi; Barbara C Silva; Ou Wang; Wei-bo Xia; Xiao-ping Xing; Wei Yu; Hua-bing Zhang; Ding-rong Zhong; Lian Zhou; Xun-wu Meng
Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(9):1967-75.
2012: S Lekamwasam; O Lesnyak; R Lorenc; E McCloskey; O D Messina; N Napoli; B Obermayer-Pietsch; S H Ralston; P N Sambrook; S Silverman; M Sosa; J Stepan; G Suppan; D A Wahl; Jonathan D Adachi; D Agnusdei; John P Bilezikian; S Boonen; Fredrik Borgström; J E Compston; C Cooper; A Diez Perez; R Eastell; L C Hofbauer; J A Kanis; B L Langdahl
A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012;23(9):2257-76.
2012: Ethel S Siris; John P Bilezikian; S Boonen; P J Mitchell; S Silverman
What's in a name? What constitutes the clinical diagnosis of osteoporosis?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012;23(8):2093-7.
2012: John P Bilezikian; Joao Lindolfo Borges; Bruno Muzzi Camargos; Didier Hans; E Michael Lewiecki; Paul D Miller; Cristiano A F Zerbini; Michael R McClung
In Memoriam: Sergio Ragi-Eis, MD, CCD, CDT (April 8, 1962–February 22, 2012).
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2012;15(3):257-9.
2012: Sundeep Khosla; E Michael Lewiecki; Paul D Miller; Robert M Neer; John P Bilezikian; David W Dempster; Robert R Recker; Elizabeth Shane; Dolores Shoback; John T Potts
Benefits and risks of bisphosphonate therapy for osteoporosis.
The Journal of clinical endocrinology and metabolism 2012;97(7):2272-82.
2012: Nelson B Watts; Robert A Adler; John P Bilezikian; Matthew T Drake; Richard Eastell; Joel S Finkelstein; Eric S Orwoll
Osteoporosis in men: an Endocrine Society clinical practice guideline.
The Journal of clinical endocrinology and metabolism 2012;97(6):1802-22.
2012: Natalie E Cusano; Mishaela R Rubin; James Sliney; John P Bilezikian
Mini-review: new therapeutic options in hypoparathyroidism.
Endocrine 2012;41(3):410-4.
2012: Marcella D Walker; Julia Udesky; John P Bilezikian; David W Dempster; Donald J McMahon; Elizabeth Shane; Shonni J Silverberg
Effect of renal function on skeletal health in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2012;97(5):1501-7.
2012: E Michael Lewiecki; Paul D Miller; John P Bilezikian
Bone-density testing interval and transition to osteoporosis.
The New England journal of medicine 2012;366(16):1546-7; author reply 1547-8.
2012: E Michael Lewiecki; Paul D Miller; Andrew J Laster; John P Bilezikian
More bone density testing is needed, not less.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(4):739-42.
2012: Aline G Costa; John P Bilezikian
Sclerostin: therapeutic horizons based upon its actions.
Current osteoporosis reports 2012;10(1):64-72.
2012: Maria-Grazia Ascenzi; John P Bilezikian; Fabrizio Billi; Felicia Cosman; Brittany M Lee; Vivian P Liao; Robert Lindsay; Jeri Nieves; Hua Zhou; David W Dempster
Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(3):702-12.
2012: Juliet E Compston; John P Bilezikian
Bisphosphonate therapy for osteoporosis: the long and short of it.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(2):240-2.
2012: E Michael Lewiecki; Eugene V McCloskey; Paul D Miller; Sarah L Morgan; Eric S Orwoll; John P Bilezikian; Lawrence G Jankowski; John T Potts
Proceedings of the 2011 Santa Fe Bone symposium.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2012;15(1):1-20.
2011: Henrique Pierotti Arantes; Elizabete Ribeiro Barros; John P Bilezikian; Ilda Kunii; Marise Lazaretti-Castro
Teriparatide increases bone mineral density in a man with osteoporosis pseudoglioma.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(12):2823-6.
2011: Anne L Schafer; Ann V Schwartz; Deborah Elaine Sellmeyer; Dolores M Shoback; Eric Vittinghoff; John P Bilezikian; Lisa Palermo; Clifford J Rosen; Dennis M Black
Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the PaTH study).
The Journal of clinical endocrinology and metabolism 2011;96(12):E1982-9.
2011: Aline G Costa; Serge Cremers; Marise Lazaretti-Castro; Donald J McMahon; Mishaela R Rubin; Shonni J Silverberg; James Sliney; John P Bilezikian
Circulating sclerostin in disorders of parathyroid gland function.
The Journal of clinical endocrinology and metabolism 2011;96(12):3804-10.
2011: Mishaela R Rubin; Elizabeth Shane; Shonni J Silverberg; James Sliney; Emily M Stein; Chiyuan Zhang; Hua Zhou; Serge Cremers; Maryann Dellabadia; David W Dempster; Elzbieta Dworakowski; Rebecca Ives; Donald J McMahon; Thomas L Nickolas; John P Bilezikian
PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(11):2727-36.
2011: John A Kanis; Jean-Marc Kaufman; S Khosla; Eric Orwoll; G Bianchi; John P Bilezikian; Ego Seeman
Towards a diagnostic and therapeutic consensus in male osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(11):2789-98.
2011: John P Bilezikian; Maria Luisa Brandi; Bart L Clarke; Michael T Collins; Pierre D'Amour; David Dempster; John Fox; Rachel Gafni; Harald Jüppner; Aliya Khan; Leif Mosekilde; John T Potts; Lars Rejnmark; Mishaela R Rubin; Dolores Shoback; Jim Sliney; James Sanders
Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(10):2317-37.
2011: John A Kanis; W D Leslie; E Michael Lewiecki; Marjorie Luckey; Eugene McCloskey; Anders Oden; Socrates E Papapoulos; C Poiana; René Rizzoli; D A Wahl; Sandord Baim; John P Bilezikian; Neil Binkley; Jane A Cauley; Juliet E Compston; C Cooper; Bess Dawson-Hughes; Ghada El-Hajj Fuleihan; Didier Hans; Helena Johansson
Interpretation and use of FRAX in clinical practice.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(9):2395-411.
2011: Natalie E Cusano; John P Bilezikian
Combination antiresorptive and osteoanabolic therapy for osteoporosis: we are not there yet.
Current medical research and opinion 2011;27(9):1705-7.
2011: Aline G Costa; Serge Cremers; Natalie E Cusano; Barbara C Silva; John P Bilezikian
Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis.
Nature reviews. Rheumatology 2011;7(8):447-56.
2011: Lorraine A Fitzpatrick; David N Gordon; Socrates Papapoulos; Henry G Bone; Gregory Cicconetti; Christine E Dabrowski; John P Bilezikian
The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density.
The Journal of clinical endocrinology and metabolism 2011;96(8):2441-9.
2011: X Sherry Liu; Donald J McMahon; Julia Udesky; Marcella D Walker; John P Bilezikian; George Liu; X Edward Guo
Better skeletal microstructure confers greater mechanical advantages in Chinese-American women versus white women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(8):1783-92.
2011: Didier Hans; John A Kanis; William D Leslie; E Michael Lewiecki; Marjorie Luckey; Eugene V McCloskey; Socrates E Papapoulos; Catalina Poiana; René Rizzoli; Sandord Baim; John P Bilezikian; Neil Binkley; Jane A Cauley; Juliet E Compston; Cyrus Cooper; Bess Dawson-Hughes; Ghada El-Hajj Fuleihan
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practice.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2011;14(3):171-80.
2011: Marcella D Walker; Bin Zhou; Ervis Bezati; X Edward Guo; George Liu; X Sherry Liu; Donald J McMahon; Elizabeth Shane; Emily Stein; Julia Udesky; John P Bilezikian
Differences in bone microarchitecture between postmenopausal Chinese-American and white women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(7):1392-8.
2011: Philippe Caron; John P Bilezikian; Tom Cantor; Jean-Christophe Maiza; Louise Rousseau; Mishaela Rubin; William F Simonds; Jean-Claude Souberbielle; Pierre D'Amour
Nontruncated amino-terminal parathyroid hormone overproduction in two patients with parathyroid carcinoma: a possible link to HRPT2 gene inactivation.
Clinical endocrinology 2011;74(6):694-8.
2011: John P Bilezikian; Marc Drezner; Barbara Kream; Paula Stern; Thomas Landes Clemens; Ann Elderkin; Ethel Siris; Stephen Krane; John Eisman; Andrew Arnold; Jean Feyen; Marja Hurley; Hiroshi Kawaguchi; Joe Lorenzo; William Peck; Carol Pilbeam; David Rowe; T Jack Martin; Janet Hock; Hector DeLuca; Sevgi Rodan; Barbara Lukert; Theresa Chen; Jenneke Klein-Nulend
Lawrence G. Raisz November 13, 1925-August 25, 2010.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011;26(5):903-11.
2011: Emily M Stein; David W Dempster; Julia Udesky; Hua Zhou; John P Bilezikian; Elizabeth Shane; Shonni J Silverberg
Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism.
Bone 2011;48(3):557-61.
2011: John P Bilezikian; John T Grbic
Bisphosphonates and osteonecrosis of the jaw: proceedings of an international conference.
Annals of the New York Academy of Sciences 2011;1218():1-2.
2011: Hyesoo Lowe; Natalie E Cusano; Neil Binkley; William S Blaner; John P Bilezikian
Vitamin D toxicity due to a commonly available "over the counter" remedy from the Dominican Republic.
The Journal of clinical endocrinology and metabolism 2011;96(2):291-5.
2011: Natalie E Cusano; Barbara C Silva; Aline G Costa; John P Bilezikian
Therapy of osteoporosis in men with teriparatide.
Journal of osteoporosis 2011;2011():463675.
2011: E Michael Lewiecki; John P Bilezikian; Sundeep Khosla; Robert Marcus; Michael R McClung; Paul D Miller; Nelson B Watts; Michael Maricic
Osteoporosis update from the 2010 santa fe bone symposium.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2011;14(1):1-21.
2011: Anne L Schafer; Lisa Palermo; Douglas Charles Bauer; John P Bilezikian; Deborah Elaine Sellmeyer; Dennis M Black
Consistency of bone turnover marker and calcium responses to parathyroid hormone (1-84) therapy in postmenopausal osteoporosis.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2011;14(1):68-73.
2011: Barbara C Silva; John P Bilezikian
New approaches to the treatment of osteoporosis.
Annual review of medicine 2011;62():307-22.
2011: Munro Peacock; John P Bilezikian; M A Bolognese; Michael Borofsky; Simona Scumpia; L R Sterling; Sunfa Cheng; Dolores Shoback
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
The Journal of clinical endocrinology and metabolism 2011;96(1):E9-18.
2011: Mishaela R Rubin; John Manavalan; David W Dempster; J Shah; S Cremers; Stavroula Kousteni; Hua Zhou; Donald J McMahon; A Kode; J Sliney; Elizabeth Shane; Shonni J Silverberg; John P Bilezikian
Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism.
The Journal of clinical endocrinology and metabolism 2011;96(1):176-86.
2010: Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2010;16 Suppl 3():1-37.
2010: Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2010;16(6):1016-9.
2010: Mishaela R Rubin; J Sliney; Donald J McMahon; Shonni J Silverberg; John P Bilezikian
Therapy of hypoparathyroidism with intact parathyroid hormone.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2010;21(11):1927-34.
2010: Annie W C Kung; Chih-Hsing Wu; Akira Itabashi; Joon Kiong Lee; Hyoung Moo Park; Yanling Zhao; Wing P Chan; David L Kendler; Edward S Leib; E Michael Lewiecki; John P Bilezikian; Sandord Baim
International Society for Clinical Densitometry official positions: Asia-Pacific Region consensus.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2010;13(4):346-51.
2010: Carolina A M Kulak; Victoria C Borba; Vanda Jorgetti; Luciene M dos Reis; Xiaowei S Liu; Donald B Kimmel; Jaime Kulak; Leda M Rabelo; Hua Zhou; X Edward Guo; John P Bilezikian; Cesar L Boguszewski; David W Dempster
Skeletal microstructural abnormalities in postmenopausal women with chronic obstructive pulmonary disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(9):1931-40.
2010: X Sherry Liu; X Henry Zhang; Kiranjit K Sekhon; Mark F Adams; Donald J McMahon; John P Bilezikian; Elizabeth Shane; X Edward Guo
High-resolution peripheral quantitative computed tomography can assess microstructural and mechanical properties of human distal tibial bone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(4):746-56.
2010: Mishaela R Rubin; John P Bilezikian
Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.
Arquivos brasileiros de endocrinologia e metabologia 2010;54(2):220-6.
2010: John P Bilezikian; Shonni J Silverberg
Normocalcemic primary hyperparathyroidism.
Arquivos brasileiros de endocrinologia e metabologia 2010;54(2):106-9.
2010: Francisco Bandeira; Marise Lazaretti-Castro; John P Bilezikian
Hormones and bone.
Arquivos brasileiros de endocrinologia e metabologia 2010;54(2):85-6.
2010: Jeri W Nieves; John P Bilezikian; J M Lane; T A Einhorn; Y Wang; M Steinbuch; Felicia Cosman
Fragility fractures of the hip and femur: incidence and patient characteristics.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2010;21(3):399-408.
2010: Adi Cohen; David W Dempster; Ralph Müller; X Edward Guo; Thomas L Nickolas; Xiaole (Shirley) Liu; X H Zhang; A J Wirth; Harry van Lenthe; T Kohler; Donald J McMahon; Hua Zhou; Mishaela R Rubin; John P Bilezikian; J M Lappe; R R Recker; Elizabeth Shane
Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2010;21(2):263-73.
2010: E Michael Lewiecki; John P Bilezikian; Andrew J Laster; Paul D Miller; Robert R Recker; R Graham G Russell; Michael P Whyte
2009 Santa Fe Bone symposium.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2010;13(1):1-9.
2010: Mishaela R Rubin; David W Dempster; Thomas Kohler; Martin Stauber; Hua Zhou; Elizabeth Shane; Thomas Nickolas; Emily Stein; James Sliney; Shonni J Silverberg; John P Bilezikian; Ralph Müller
Three dimensional cancellous bone structure in hypoparathyroidism.
Bone 2010;46(1):190-5.
2009: Marcella D Walker; Donald J McMahon; Julia Udesky; George Liu; John P Bilezikian
Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(12):1953-9.
2009: Aliya A Khan; John P Bilezikian; Annie Kung; Sacha J Dubois; Timothy I Standish; Zeba A Syed
Alendronate therapy in men with primary hyperparathyroidism.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15(7):705-13.
2009: Nelson B Watts; E Michael Lewiecki; Sydney L Bonnick; Andrew J Laster; Neil Binkley; Robert D Blank; Piet P Geusens; Paul D Miller; Steven M Petak; Robert R Recker; Kenneth G Saag; John Schousboe; Ethel S Siris; John P Bilezikian
Clinical value of monitoring BMD in patients treated with bisphosphonates for osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(10):1643-6.
2009: Aliya A Khan; John P Bilezikian; John T Potts
Asymptomatic primary hyperparathyroidism: a commentary on the revised guidelines.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15(5):494-8.
2009: E Michael Lewiecki; Sandord Baim; Craig B Langman; John P Bilezikian
The official positions of the International Society for Clinical Densitometry: perceptions and commentary.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2009;12(3):267-71.
2009: Edda Vignali; Giuseppe Viccica; Daniele Diacinti; Filomena Cetani; Luisella Cianferotti; Elena Ambrogini; Chiara Banti; Romano Del Fiacco; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2009;94(7):2306-12.
2009: Ethel S Siris; Martin W Oster; John P Bilezikian
More on reports of esophageal cancer with oral bisphosphonate use.
The New England journal of medicine 2009;360(17):1791; author reply 1791-2.
2009: Luigi Gennari; John P Bilezikian
Glucocorticoid-induced osteoporosis: hope on the HORIZON.
Lancet 2009;373(9671):1225-6.
2009: E Michael Lewiecki; Sandord Baim; John P Bilezikian; Ana Munoz; Meryl Leboff; Paul D Miller
2008 Santa Fe Bone Symposium: update on osteoporosis.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2009;12(2):135-57.
2009: John P Bilezikian; Toshio Matsumoto; Teresita Bellido; Sundeep Khosla; Jack Martin; Robert R Recker; Robert Heaney; Ego Seeman; Socrates Papapoulos; Steven R Goldring
Targeting bone remodeling for the treatment of osteoporosis: summary of the proceedings of an ASBMR workshop.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2009;24(3):373-85.
2009: Gherardo Mazziotti; Ernesto Canalis; Andrea Giustina; John P Bilezikian
Treatment of glucocorticoid-induced osteoporsis.
Therapeutic advances in musculoskeletal disease 2009;1(1):27-34.
2009: John P Bilezikian; Aliya A Khan; John T Potts
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.
The Journal of clinical endocrinology and metabolism 2009;94(2):335-9.
2009: Aliya A Khan; John P Bilezikian; John T Potts
The diagnosis and management of asymptomatic primary hyperparathyroidism revisited.
The Journal of clinical endocrinology and metabolism 2009;94(2):333-4.
2009: John P Bilezikian
Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.
The American journal of medicine 2009;122(2 Suppl):S14-21.
2008: Claudio Marcocci; Filomena Cetani; Mishaela R Rubin; Shonni J Silverberg; Aldo Pinchera; John P Bilezikian
Parathyroid carcinoma.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(12):1869-80.
2008: E Michael Lewiecki; Catherine M Gordon; Sandord Baim; Mary B Leonard; Nicholas J Bishop; Maria-Luisa Bianchi; Heidi J Kalkwarf; Craig B Langman; Horacio Plotkin; Frank Rauch; Babette S Zemel; Neil Binkley; John P Bilezikian; David L Kendler; Didier B Hans; Stuart Silverman
International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions.
Bone 2008;43(6):1115-21.
2008: Mishaela R Rubin; David W Dempster; Hua Zhou; Elizabeth Shane; Thomas Nickolas; James Sliney; Shonni J Silverberg; John P Bilezikian
Dynamic and structural properties of the skeleton in hypoparathyroidism.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(12):2018-24.
2008: Tony M Keaveny; Paul F Hoffmann; Mandeep Singh; Lisa Palermo; John P Bilezikian; Susan L Greenspan; Dennis M Black
Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(12):1974-82.
2008: Mami Ogita; Marie Therese Rached; Elzbieta Dworakowski; John P Bilezikian; Stavroula Kousteni
Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration.
Endocrinology 2008;149(11):5713-23.
2008: Luigi Gennari; Sundeep Khosla; John P Bilezikian
Estrogen and fracture risk in men.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(10):1548-51.
2008: Paul D Miller; Pierre D Delmas; Robert Lindsay; Nelson B Watts; Marjorie Luckey; Jonathan Adachi; Kenneth G Saag; Susan L Greenspan; Ego Seeman; Steven Boonen; Suzanne Meeves; Thomas Lang; John P Bilezikian
Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate.
The Journal of clinical endocrinology and metabolism 2008;93(10):3785-93.
2008: E Michael Lewiecki; C M Gordon; Sandord Baim; Neil Binkley; John P Bilezikian; David L Kendler; D B Hans; S Silverman; N J Bishop; M B Leonard; Maria Luisa BIANCHI; H J Kalkwarf; C B Langman; Horacio Plotkin; F Rauch; B S Zemel
Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(10):1369-78.
2008: Mishaela R Rubin; John P Bilezikian; Steven Birken; Shonni J Silverberg
Human chorionic gonadotropin measurements in parathyroid carcinoma.
European journal of endocrinology / European Federation of Endocrine Societies 2008;159(4):469-74.
2008: Ruth Zoehrer; David W Dempster; John P Bilezikian; Hua Zhou; Shonni J Silverberg; Elizabeth Shane; Paul Roschger; Eleftherios P Paschalis; Klaus Klaushofer
Bone quality determined by Fourier transform infrared imaging analysis in mild primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2008;93(9):3484-9.
2008: Mishaela R Rubin; John P Bilezikian; Donald J McMahon; Thomas Jacobs; Elizabeth Shane; Ethel S Siris; Julia Udesky; Shonni J Silverberg
The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.
The Journal of clinical endocrinology and metabolism 2008;93(9):3462-70.
2008: Patrick Garnero; Douglas Charles Bauer; Emmanuel Mareau; John P Bilezikian; Susan L Greenspan; Clifford Rosen; Dennis Black
Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(9):1442-8.
2008: Mauro Doga; Gherardo Mazziotti; Stefania Bonadonna; I Patelli; John P Bilezikian; E Canalis; Andrea Giustina
Prevention and treatment of glucocorticoid-induced osteoporosis.
Journal of endocrinological investigation 2008;31(7 Suppl):53-8.
2008: E Michael Lewiecki; Sandord Baim; Neil Binkley; John P Bilezikian; David L Kendler; Didier B Hans; Stuart Silverman
Report of the International Society for Clinical Densitometry 2007 Adult Position Development Conference and Official Positions.
Southern medical journal 2008;101(7):735-9.
2008: Lorraine A Fitzpatrick; John P Bilezikian; Shonni J Silverberg
Parathyroid hormone and the cardiovascular system.
Current osteoporosis reports 2008;6(2):77-83.
2008: Stavroula Kousteni; John P Bilezikian
The cell biology of parathyroid hormone in osteoblasts.
Current osteoporosis reports 2008;6(2):72-6.
2008: Marcella D Walker; Rachel Novotny; John P Bilezikian; Connie M Weaver
Race and diet interactions in the acquisition, maintenance, and loss of bone.
The Journal of nutrition 2008;138(6):1256S-60S.
2008: Susan Thys-Jacobs; Don McMahon; John P Bilezikian
Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
American journal of obstetrics and gynecology 2008;198(5):506.e1-8.
2008: E Michael Lewiecki; John P Bilezikian; Cyrus Cooper; Marc C Hochberg; Marjorie M Luckey; Michael Maricic; Paul D Miller
Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2008;11(2):313-24.
2008: John P Bilezikian
Combination anabolic and antiresorptive therapy for osteoporosis: opening the anabolic window.
Current osteoporosis reports 2008;6(1):24-30.
2008: Serge Cremers; John P Bilezikian; Patrick Garnero
Bone markers--new aspects.
Clinical laboratory 2008;54(11-12):461-71.
2008: Sandord Baim; Neil Binkley; John P Bilezikian; David L Kendler; Didier Hans; E Michael Lewiecki; Stuart Silverman
Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2008;11(1):75-91.
2008: Jhansi Reddy; John P Bilezikian; Suzanne J Smith; Lori Mosca
Reduced bone mineral density is associated with breast arterial calcification.
The Journal of clinical endocrinology and metabolism 2008;93(1):208-11.
2008: Susan Thys-Jacobs; Don McMahon; John P Bilezikian
Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder.
The Journal of clinical endocrinology and metabolism 2008;93(1):96-102.
2007: Gherardo Mazziotti; Andrea Giustina; Ernesto Canalis; John P Bilezikian
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.
Arquivos brasileiros de endocrinologia e metabologia 2007;51(8):1404-12.
2007: Shonni J Silverberg; Mishaela R Rubin; C Faiman; Munro Peacock; Dolores Shoback; R C Smallridge; L E Schwanauer; Kurt A Olson; Preston S Klassen; John P Bilezikian
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2007;92(10):3803-8.
2007: E Canalis; G Mazziotti; A Giustina; John P Bilezikian
Glucocorticoid-induced osteoporosis: pathophysiology and therapy.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(10):1319-28.
2007: Paul D Miller; John P Bilezikian; Manuel Diaz-Curiel; Peiqi Chen; Fernando Marin; John Krege; Mayme Wong; Robert Marcus
Occurrence of hypercalciuria in patients with osteoporosis treated with teriparatide.
The Journal of clinical endocrinology and metabolism 2007;92(9):3535-41.
2007: Ernesto Canalis; Andrea Giustina; John P Bilezikian
Mechanisms of anabolic therapies for osteoporosis.
The New England journal of medicine 2007;357(9):905-16.
2007: Mishaela R Rubin; Shonni J Silverberg; Pierre D'Amour; Jean-Hugues Brossard; Louise Rousseau; James Sliney; Tom Cantor; John P Bilezikian
An N-terminal molecular form of parathyroid hormone (PTH) distinct from hPTH(1 84) is overproduced in parathyroid carcinoma.
Clinical chemistry 2007;53(8):1470-6.
2007: H Lowe; Donald J McMahon; Mishaela R Rubin; John P Bilezikian; Shonni J Silverberg
Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
The Journal of clinical endocrinology and metabolism 2007;92(8):3001-5.
2007: Elena Ambrogini; Filomena Cetani; Luisella Cianferotti; Edda Vignali; Chiara Banti; Giuseppe Viccica; Annalisa Oppo; Paolo Miccoli; Piero Berti; John P Bilezikian; Aldo Pinchera; Claudio Marcocci
Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.
The Journal of clinical endocrinology and metabolism 2007;92(8):3114-21.
2007: Susan Thys-Jacobs; Don McMahon; John P Bilezikian
Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder.
The Journal of clinical endocrinology and metabolism 2007;92(8):2952-9.
2007: Deborah Elaine Sellmeyer; Dennis M Black; Lisa Palermo; Susan L Greenspan; K Ensrud; John P Bilezikian; C J Rosen
Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(7):973-9.
2007: Luigi Gennari; John P Bilezikian
Osteoporosis in men.
Endocrinology and metabolism clinics of North America 2007;36(2):399-419.
2007: Victória Z C Borba; Paz-Filho Gilberto; Carolina A M Kulak; M J Seibel; John P Bilezikian
Bone turnover 18 months after a single intravenous dose of zoledronic acid.
International journal of clinical practice 2007;61(6):1058-62.
2007: Neil Binkley; John P Bilezikian; David L Kendler; Edward S Leib; E Michael Lewiecki; Steven M Petak
Summary of the International Society For Clinical Densitometry 2005 Position Development Conference.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(5):643-5.
2007: Paul Roschger; David W Dempster; Hua Zhou; Eleftherios P Paschalis; Shonni J Silverberg; Elizabeth Shane; John P Bilezikian; Klaus Klaushofer
New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2007;22(5):717-23.
2007: Carolina A M Kulak; Victória Z C Borba; Carlos Eduardo Silvado; Luciano de Paola; Markus J Seibel; John P Bilezikian; Cesar Luiz Boguszewski
Bone density and bone turnover markers in patients with epilepsy on chronic antiepileptic drug therapy.
Arquivos brasileiros de endocrinologia e metabologia 2007;51(3):466-71.
2007: Luigi Gennari; John P Bilezikian
Osteoporosis in men: pathophysiology and treatment.
Current rheumatology reports 2007;9(1):71-7.
2007: M D Walker; Rajeev K Babbar; Alexander Opotowsky; Donald J McMahon; G Liu; John P Bilezikian
Determinants of bone mineral density in Chinese-American women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2007;18(4):471-8.
2007: John P Bilezikian
Anabolic therapy for osteoporosis.
Women's health (London, England) 2007;3(2):243-53.
2007: Luigi Gennari; John P Bilezikian
Osteoporosis in men: pathophysiology and treatment.
Current osteoporosis reports 2007;5(1):22-8.
2007: Diana M Antoniucci; Deborah Elaine Sellmeyer; John P Bilezikian; Lisa Palermo; Kristine E Ensrud; Susan L Greenspan; Dennis M Black
Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.
The Journal of clinical endocrinology and metabolism 2007;92(3):942-7.
2006: John P Bilezikian
Osteonecrosis of the jaw--do bisphosphonates pose a risk?
The New England journal of medicine 2006;355(22):2278-81.
2006: Nelson B Watts; Steven T Harris; Michael R McClung; John P Bilezikian; Susan L Greenspan; Marjorie M Luckey
Bisphosphonates and osteonecrosis of the jaw.
Annals of internal medicine 2006;145(10):791-2; author reply 792.
2006: Edward S Leib; Neil Binkley; John P Bilezikian; David L Kendler; E Michael Lewiecki; Steven M Petak
Position Development Conference of the International Society for Clinical Densitometry. Vancouver, BC, July 15-17, 2005.
The Journal of rheumatology 2006;33(11):2319-21.
2006: Shonni J Silverberg; John P Bilezikian
The diagnosis and management of asymptomatic primary hyperparathyroidism.
Nature clinical practice. Endocrinology & metabolism 2006;2(9):494-503.
2006: Chhavi Agarwal; Robert Seigle; Sanjeev Agarwal; John P Bilezikian; Joshua E Hyman; Sharon E Oberfield
Pseudohypoparathyroidism: a rare cause of bilateral slipped capital femoral epiphysis.
The Journal of pediatrics 2006;149(3):406-8.
2006: João Lindolfo C Borges; John P Bilezikian
Update on osteoporosis therapy.
Arquivos brasileiros de endocrinologia e metabologia 2006;50(4):755-63.
2006: Monica Girotra; Mishaela R Rubin; John P Bilezikian
Anabolic skeletal therapy for osteoporosis.
Arquivos brasileiros de endocrinologia e metabologia 2006;50(4):745-54.
2006: John P Bilezikian; Mishaela Rubin; Shonni J Silverberg
Asymptomatic primary hyperparathyroidism.
Arquivos brasileiros de endocrinologia e metabologia 2006;50(4):647-56.
2006: Monica Girotra; Mishaela R Rubin; John P Bilezikian
The use of parathyroid hormone in the treatment of osteoporosis.
Reviews in endocrine & metabolic disorders 2006;7(1-2):113-21.
2006: Gherardo Mazziotti; Alberto Angeli; John P Bilezikian; Ernesto Canalis; Andrea Giustina
Glucocorticoid-induced osteoporosis: an update.
Trends in endocrinology and metabolism: TEM 2006;17(4):144-9.
2006: John P Bilezikian
What's good for the goose's skeleton is good for the gander's skeleton.
The Journal of clinical endocrinology and metabolism 2006;91(4):1223-5.
2006: John P Bilezikian; Mishaela R Rubin
Combination/sequential therapies for anabolic and antiresorptive skeletal agents for osteoporosis.
Current osteoporosis reports 2006;4(1):5-13.
2006: Monica Girotra; Mishaela R Rubin; John P Bilezikian
Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?
Treatments in endocrinology 2006;5(6):347-58.
2006: E Michael Lewiecki; Neil Binkley; John P Bilezikian; David L Kendler; Edward S Leib; Steven M Petak
Official positions of the International Society for Clinical Densitometry.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(11):1700-1.
2006: Aliya Khan; David A Hanley; John P Bilezikian; Neil Binkley; Jacques P Brown; Anthony B Hodsman; Robert G Josse; David L Kendler; E Michael Lewiecki; Paul D Miller; Wojciech P Olszynski; Steven M Petak; Zeba A Syed; Diane Theriault; Nelson B Watts
Standards for performing DXA in individuals with secondary causes of osteoporosis.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2006;9(1):47-57.
2006: Neil Binkley; John P Bilezikian; David L Kendler; Edward S Leib; E Michael Lewiecki; Steven M Petak
Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2006;9(1):4-14.
2006: M Donovan Walker; Rajeev K Babbar; Alexander Opotowsky; A Rohira; F Nabizadeh; M Della Badia; W Chung; J Chiang; A Mediratta; Don McMahon; G Liu; John P Bilezikian
A referent bone mineral density database for Chinese American women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2006;17(6):878-87.
2005: Thomas P Jacobs; John P Bilezikian
Clinical review: Rare causes of hypercalcemia.
The Journal of clinical endocrinology and metabolism 2005;90(11):6316-22.
2005: Dennis M Black; John P Bilezikian; Kristine E Ensrud; Susan L Greenspan; Lisa Palermo; Trisha Hue; Thomas Lang; Joan A McGowan; Clifford J Rosen
One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.
The New England journal of medicine 2005;353(6):555-65.
2005: Mishaela R Rubin; Matthew Maurer; Donald J McMahon; John P Bilezikian; Shonni J Silverberg
Arterial stiffness in mild primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2005;90(6):3326-30.
2005: Mishaela R Rubin; Debra H Schussheim; Carolina A M Kulak; Etah S Kurland; Clifford J Rosen; John P Bilezikian; Elizabeth Shane
Idiopathic osteoporosis in premenopausal women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(5):526-33.
2005: John P Bilezikian
Anabolic therapy for osteoporosis.
International journal of fertility and women's medicine 2005;50(2):53-60.
2005: Stefania Bonadonna; Anna Burattin; Monica Nuzzo; Giovanna Bugari; Enrico Agabiti Rosei; Domenico Valle; Nicoletta Iori; John P Bilezikian; Johannes D Veldhuis; Andrea Giustina
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects.
European journal of endocrinology / European Federation of Endocrine Societies 2005;152(2):199-205.
2005: John P Bilezikian; Mishaela R Rubin; J S Finkelstein
Parathyroid hormone as an anabolic therapy for women and men.
Journal of endocrinological investigation 2005;28(8 Suppl):41-9.
2005: Mishaela R Rubin; John P Bilezikian
Parathyroid hormone as an anabolic skeletal therapy.
Drugs 2005;65(17):2481-98.
2005: E Michael Lewiecki; Paul D Miller; Edward S Leib; John P Bilezikian
Response to "The Perspective of the International Osteoporosis Foundation on the Official Positions of the International Society for Clinical Densitometry," by John A. Kanis et al.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2005;8(2):143-4.
2005: John P Bilezikian; M L Brandi; M Rubin; Shonni J Silverberg
Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features.
Journal of internal medicine 2005;257(1):6-17.
2005: Munro Peacock; John P Bilezikian; Preston S Klassen; Matthew D Guo; Stewart A Turner; Dolores Shoback
Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2005;90(1):135-41.
2004: Carolina A M Kulak; Victória Z C Borba; John P Bilezikian; Carlos Eduardo Silvado; Luciano de Paola; Cesar Luiz Boguszewski
Bone mineral density and serum levels of 25 OH vitamin D in chronic users of antiepileptic drugs.
Arquivos de neuro-psiquiatria 2004;62(4):940-8.
2004: Luigi Gennari; Ranuccio Nuti; John P Bilezikian
Aromatase activity and bone homeostasis in men.
The Journal of clinical endocrinology and metabolism 2004;89(12):5898-907.
2004: Etah S Kurland; Samantha L Heller; Beverly Diamond; Donald J McMahon; Felicia Cosman; John P Bilezikian
The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)].
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2004;15(12):992-7.
2004: Alexander Opotowsky; John P Bilezikian
Serum vitamin A concentration and the risk of hip fracture among women 50 to 74 years old in the United States: a prospective analysis of the NHANES I follow-up study.
The American journal of medicine 2004;117(3):169-74.
2004: Aliya Khan; John P Bilezikian; Annie W C Kung; Mustafa M Ahmed; Sacha J Dubois; Andrew Y Y Ho; Debra H Schussheim; Mishaela R Rubin; Atif M Shaikh; Shonni J Silverberg; Timothy I Standish; Zeba A Syed; Zeba A Syed
Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
The Journal of clinical endocrinology and metabolism 2004;89(7):3319-25.
2004: Shonni J Silverberg; John P Bilezikian
Asymptomatic primary hyperparathyroidism: a medical perspective.
The Surgical clinics of North America 2004;84(3):787-801.
2004: John P Bilezikian; Shonni J Silverberg
Clinical practice. Asymptomatic primary hyperparathyroidism.
The New England journal of medicine 2004;350(17):1746-51.
2004: Ernesto Canalis; John P Bilezikian; Alberto Angeli; Andrea Giustina
Perspectives on glucocorticoid-induced osteoporosis.
Bone 2004;34(4):593-8.
2004: Paul D Miller; John P Bilezikian; Chad Deal; Steven T Harris; Roberto Pa Ci
Clinical use of teriparatide in the real world: initial insights.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2004;10(2):139-48.
2004: Jean E Mulder; John P Bilezikian
Bone density in survivors of childhood cancer.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2004;7(4):432-42.
2003: Dolores Shoback; John P Bilezikian; Stewart A Turner; Laura C McCary; Matthew D Guo; Munro Peacock
The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2003;88(12):5644-9.
2003: Stephen F Hodgson; Nelson B Watts; John P Bilezikian; Bart L Clarke; T Kenney Gray; David W Harris; C Conrad Johnston; Michael Kleerekoper; Robert Lindsay; Marjorie M Luckey; Michael R McClung; Howard R Nankin; Steven M Petak; Robert R Recker
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2003;9(6):544-64.
2003: Alexander Opotowsky; John P Bilezikian
Racial differences in the effect of early milk consumption on peak and postmenopausal bone mineral density.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(11):1978-88.
2003: Shonni J Silverberg; John P Bilezikian
"Incipient" primary hyperparathyroidism: a "forme fruste" of an old disease.
The Journal of clinical endocrinology and metabolism 2003;88(11):5348-52.
2003: Shonni J Silverberg; Ping Gao; Ijeoma Brown; Paul LoGerfo; Tom Cantor; John P Bilezikian
Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 2003;88(10):4725-30.
2003: Dennis M Black; Susan L Greenspan; Kristine E Ensrud; Lisa Palermo; Joan A McGowan; Thomas Lang; Patrick Garnero; Mary L Bouxsein; John P Bilezikian; Clifford J Rosen
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.
The New England journal of medicine 2003;349(13):1207-15.
2003: John P Bilezikian
Bone strength in primary hyperparathyroidism.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2003;14 Suppl 5():S113-5; discussion S115-7.
2003: Alexander Opotowsky; Brian W Su; John P Bilezikian
Height and lower extremity length as predictors of hip fracture: results of the NHANES I Epidemiologic Follow-up Study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(9):1674-81.
2003: Ethel S Siris; John P Bilezikian; Mishaela R Rubin; Dennis M Black; Richard S Bockman; Henry G Bone; Marc C Hochberg; Michael R McClung; Thomas J Schnitzer
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures.
The Journal of clinical endocrinology and metabolism 2003;88(8):3482-6.
2003: Mishaela R Rubin; John P Bilezikian
The anabolic effects of parathyroid hormone therapy.
Clinics in geriatric medicine 2003;19(2):415-32.
2003: John P Bilezikian
When should a gynecologist refer a patient for specialty care in osteoporosis?
International journal of fertility and women's medicine 2003;48(3):132-6; discussion 137-8.
2003: Govind Bhagat; Daniel Leffler; John P Bilezikian; Peter H R Green
Cystosarcoma phyllodes of the breast occurring in a child with subsequent diagnosis of celiac disease.
Journal of pediatric gastroenterology and nutrition 2003;36(5):644-6.
2003: Mishaela R Rubin; John P Bilezikian
New anabolic therapies in osteoporosis.
Endocrinology and metabolism clinics of North America 2003;32(1):285-307.
2003: Sundeep Khosla; John P Bilezikian
The role of estrogens in men and androgens in women.
Endocrinology and metabolism clinics of North America 2003;32(1):195-218.
2003: Barbara M Misof; Paul Roschger; Felicia Cosman; Etah S Kurland; Walter Tesch; Phaedra Messmer; David W Dempster; Jeri W Nieves; Elizabeth Shane; Peter Fratzl; Klaus Klaushofer; John P Bilezikian; Robert Lindsay
Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment.
The Journal of clinical endocrinology and metabolism 2003;88(3):1150-6.
2002: Shonni J Silverberg; Ijeoma Brown; John P Bilezikian
Age as a criterion for surgery in primary hyperparathyroidism.
The American journal of medicine 2002;113(8):681-4.
2002: John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.
The Journal of clinical endocrinology and metabolism 2002;87(12):5353-61.
2002: Paul D Miller; John P Bilezikian
Bone densitometry in asymptomatic primary hyperparathyroidism.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17 Suppl 2():N98-102.
2002: John P Bilezikian; John T Potts
Asymptomatic primary hyperparathyroidism: new issues and new questions--bridging the past with the future.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17 Suppl 2():N57-67.
2002: John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17 Suppl 2():N2-11.
2002: Kazuhide Ogino; Kazuyoshi Ogura; Yoshiharu Kinugasa; Yoshiyuki Furuse; Kazuhiko Uchida; Masaki Shimoyama; Toru Kinugawa; Shuichi Osaki; Masahiko Kato; Yoko Tomikura; Osamu Igawa; Ichiro Hisatome; John P Bilezikian; Chiaki Shigemasa
Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure.
The Journal of clinical endocrinology and metabolism 2002;87(10):4722-7.
2002: Hong Gao; Peter V N Bodine; Richard Murrills; Frederick J Bex; John P Bilezikian; Stephen A Morris
PTH-dependent adenylyl cyclase activation in SaOS-2 cells: passage dependent effects on G protein interactions.
Journal of cellular physiology 2002;193(1):10-8.
2002: Mishaela R Rubin; John P Bilezikian
Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence.
The Journal of clinical endocrinology and metabolism 2002;87(9):4033-41.
2002: Mishaela R Rubin; John P Bilezikian
New anabolic therapies in osteoporosis.
Current opinion in rheumatology 2002;14(4):433-40.
2002: Norman H Bell; John P Bilezikian; Henry G Bone; Amarjot Kaur; Adele Maragoto; Arthur C Santora
Alendronate increases bone mass and reduces bone markers in postmenopausal African-American women.
The Journal of clinical endocrinology and metabolism 2002;87(6):2792-7.
2002: Mishaela R Rubin; John P Bilezikian
The potential of parathyroid hormone as a therapy for osteoporosis.
International journal of fertility and women's medicine 2002;47(3):103-15.
2002: John P Bilezikian
Sex steroids, mice, and men: when androgens and estrogens get very close to each other.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(4):563-6.
2002: Bruce Ettinger; John P Bilezikian
For osteoporosis, are two antiresorptive drugs better than one?
The Journal of clinical endocrinology and metabolism 2002;87(3):983-4.
2002: Edward S Leib; Leon Lenchik; John P Bilezikian; Michael Maricic; Nelson B Watts
Position statements of the International Society for Clinical Densitometry: methodology.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2002;5 Suppl():S5-10.
2002: Mishaela R Rubin; Felicia Cosman; Robert Lindsay; John P Bilezikian
The anabolic effects of parathyroid hormone.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2002;13(4):267-77.
2001: Mishaela R Rubin; V A Livolsi; Francisco Bandeira; Gustavo Caldas; John P Bilezikian
Tc99m-sestamibi uptake in osteitis fibrosa cystica simulating metastatic bone disease.
The Journal of clinical endocrinology and metabolism 2001;86(11):5138-41.
2001: John P Bilezikian; Etah S Kurland
Therapy of male osteoporosis with parathyroid hormone.
Calcified tissue international 2001;69(4):248-51.
2001: Masaki Shimoyama; Kazuhide Ogino; Yoshiyuki Furuse; Kazuhiko Uchida; Yoshiharu Kinugasa; Yoko Tomikura; Osamu Igawa; Ichiro Hisatome; John P Bilezikian; Chiaki Shigemasa
Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart.
Journal of cardiovascular pharmacology 2001;38(4):491-9.
2001: David W Dempster; Felicia Cosman; Etah S Kurland; H Zhou; Jeri W Nieves; Lillian Woelfert; Elizabeth Shane; K Plavetić; R Müller; John P Bilezikian; Robert Lindsay
Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2001;16(10):1846-53.
2001: Masaki Shimoyama; Kazuhide Ogino; Kazuhiko Uchida; Yoshiyuki Furuse; Yoshiharu Kinugasa; S Taniguchi; Osamu Igawa; Ichiro Hisatome; John P Bilezikian; Chiaki Shigemasa
Fragment-specific actions of parathyroid hormone in isolated perfused rat hearts.
Calcified tissue international 2001;69(2):88-93.
2001: John P Bilezikian
The role of estrogens in male skeletal development.
Reproduction, fertility, and development 2001;13(4):253-9.
2000: John P Bilezikian; Shonni J Silverberg
Clinical spectrum of primary hyperparathyroidism.
Reviews in endocrine & metabolic disorders 2000;1(4):237-45.
2000: John P Bilezikian
Primary hyperparathyroidism. When to observe and when to operate.
Endocrinology and metabolism clinics of North America 2000;29(3):465-78.
2000: Etah S Kurland; Felicia Cosman; Donald J McMahon; Clifford J Rosen; Robert Lindsay; John P Bilezikian
Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
The Journal of clinical endocrinology and metabolism 2000;85(9):3069-76.
2000: C A Moreira Kulak; Debra H Schussheim; Donald J McMahon; Etah S Kurland; Shonni J Silverberg; Ethel S Siris; John P Bilezikian; Elizabeth Shane
Osteoporosis and low bone mass in premenopausal and perimenopausal women.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2000;6(4):296-304.
2000: Marie Thearle; Mary Horlick; John P Bilezikian; J Levy; Joseph Gertner; Lenore S Levine; M Harbison; W Berdon; Sharon E Oberfield
Osteoporosis: an unusual presentation of childhood Crohn's disease.
The Journal of clinical endocrinology and metabolism 2000;85(6):2122-6.
2000: John P Bilezikian; X Meng; Y Shi; S J Silverberg
Primary hyperparathyroidism in women: a tale of two cities--New York and Beijing.
International journal of fertility and women's medicine 2000;45(2):158-65.
1999: Shonni J Silverberg; Elizabeth Shane; David W Dempster; John P Bilezikian
The effects of vitamin D insufficiency in patients with primary hyperparathyroidism.
The American journal of medicine 1999;107(6):561-7.
1999: John P Bilezikian
The importance of calcium in postmenopausal women.
American journal of therapeutics 1999;6(6):325-6.
1999: Carolina A M Kulak; John P Bilezikian
Bone mass measurement in identification of women at risk for osteoporosis.
International journal of fertility and women's medicine 1999;44(6):269-78.
1999: Shonni J Silverberg; Elizabeth Shane; Thomas P Jacobs; Ethel S Siris; John P Bilezikian
A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.
The New England journal of medicine 1999;341(17):1249-55.
1999: John P Bilezikian
Osteoporosis in men.
The Journal of clinical endocrinology and metabolism 1999;84(10):3431-4.
1999: Shonni J Silverberg; John P Bilezikian; Henry G Bone; Gary B Talpos; M J Horwitz; A F Stewart
Therapeutic controversies in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1999;84(7):2275-85.
1999: Susan Thys-Jacobs; Daniel Donovan; A Papadopoulos; P Sarrel; John P Bilezikian
Vitamin D and calcium dysregulation in the polycystic ovarian syndrome.
Steroids 1999;64(6):430-5.
1999: Paul D Miller; C Zapalowski; C A Kulak; John P Bilezikian
Bone densitometry: the best way to detect osteoporosis and to monitor therapy.
The Journal of clinical endocrinology and metabolism 1999;84(6):1867-71.
1999: K Boncimino; Donald J McMahon; Vicki Addesso; John P Bilezikian; Elizabeth Shane
Magnesium deficiency and bone loss after cardiac transplantation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(2):295-303.
1999: S A Morris; H Shen; Frederick J Bex; John P Bilezikian
Influence of antiresorptive agent OST-766 on signal transduction pathways involved in parathyroid hormone action.
Calcified tissue international 1999;64(2):148-53.
1998: John P Bilezikian; A Morishima; J Bell; M M Grumbach
Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.
The New England journal of medicine 1998;339(9):599-603.
1998: Etah S Kurland; F K Chan; Clifford J Rosen; John P Bilezikian
Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I.
The Journal of clinical endocrinology and metabolism 1998;83(7):2576-9.
1998: C J Rosen; Etah S Kurland; D Vereault; R A Adler; Paula Rackoff; W Y Craig; S Witte; J Rogers; John P Bilezikian
Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density.
The Journal of clinical endocrinology and metabolism 1998;83(7):2286-90.
1998: Carolina A M Kulak; John P Bilezikian
Osteoporosis: preventive strategies.
International journal of fertility and women's medicine 1998;43(2):56-64.
1998: Carolina A M Kulak; Cristina Bandeira; D Voss; S M Sobieszczyk; Shonni J Silverberg; Francisco Bandeira; John P Bilezikian
Marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica.
The Journal of clinical endocrinology and metabolism 1998;83(3):732-5.
1997: Shonni J Silverberg; Henry G Bone; Thomas B Marriott; F G Locker; Susan Thys-Jacobs; G Dziem; Scott S Kaatz; E L Sanguinetti; John P Bilezikian
Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism.
The New England journal of medicine 1997;337(21):1506-10.
1997: Motoki Hara; Y M Liu; L Zhen; Ira S Cohen; Han-Gang Yu; Peter Danilo; K Ogino; John P Bilezikian; Michael R Rosen
Positive chronotropic actions of parathyroid hormone and parathyroid hormone-related peptide are associated with increases in the current, I(f), and the slope of the pacemaker potential.
Circulation 1997;96(10):3704-9.
1997: Etah S Kurland; Clifford J Rosen; Felicia Cosman; Don McMahon; F Chan; Elizabeth Shane; Robert Lindsay; David W Dempster; John P Bilezikian
Insulin-like growth factor-I in men with idiopathic osteoporosis.
The Journal of clinical endocrinology and metabolism 1997;82(9):2799-805.
1997: F G Locker; Shonni J Silverberg; John P Bilezikian
Optimal dietary calcium intake in primary hyperparathyroidism.
The American journal of medicine 1997;102(6):543-50.
1997: F K Chan; L M Koberle; Susan Thys-Jacobs; John P Bilezikian
Differential diagnosis, causes, and management of hypercalcemia.
Current problems in surgery 1997;34(6):445-523.
1996: Shonni J Silverberg; F G Locker; John P Bilezikian
Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1996;81(11):4007-12.
1996: Herbert B Tanowitz; Murray Wittner; B Chen; Huan Huang; Louis M Weiss; George Christ; Vicki L Braunstein; John P Bilezikian; Stephen A Morris
Effects of verapamil on acute murine Chagas' disease.
The Journal of parasitology 1996;82(5):814-9.
1996: Shonni J Silverberg; John P Bilezikian
Evaluation and management of primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1996;81(6):2036-40.
1996: Lena S Sun; F Huber; Richard B Robinson; John P Bilezikian; Susan F Steinberg; Yvonne Vulliemoz
Muscarinic receptor heterogeneity in neonatal rat ventricular myocytes in culture.
Journal of cardiovascular pharmacology 1996;27(4):455-61.
1996: John P Bilezikian
Current and future nonhormonal approaches to the treatment of osteoporosis.
International journal of fertility and menopausal studies 1996;41(2):148-55.
1995: May Parisien; Felicia Cosman; R W Mellish; M Schnitzer; Jeri W Nieves; Shonni J Silverberg; Elizabeth Shane; D Kimmel; R R Recker; John P Bilezikian
Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(9):1393-9.
1995: K Ogino; D Burkhoff; John P Bilezikian
The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein.
Endocrinology 1995;136(7):3024-30.
1995: S Koga; S Morris; S Ogawa; Hui Liao; John P Bilezikian; G Chen; W J Thompson; T Ashikaga; J Brett; David M Stern
TNF modulates endothelial properties by decreasing cAMP.
The American journal of physiology 1995;268(5 Pt 1):C1104-13.
1995: Shonni J Silverberg; F Gartenberg; Thomas P Jacobs; Elizabeth Shane; Ethel S Siris; Ronald B Staron; D J McMahon; John P Bilezikian
Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1995;80(3):729-34.
1995: Shonni J Silverberg; F Gartenberg; Thomas P Jacobs; Elizabeth Shane; Ethel S Siris; Ronald B Staron; John P Bilezikian
Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1995;80(3):723-8.
1995: Huan Huang; Murray Wittner; Herbert B Tanowitz; John P Bilezikian; Stephen A Morris; H Huan
Release of guanosine triphosphate binding protein alpha subunits from mouse myocardial membranes: basic properties and their alterations in acute murine Chagas disease.
Cardiovascular research 1995;29(3):350-8.
1995: E M Horn; Marrick L Kukin; G W Neuberg; Rochelle L Goldsmith; M McCarty; M Gratch; N Medina; M Yushak; Milton Packer; John P Bilezikian
Lymphocyte G proteins reflect response to treatment in congestive heart failure.
American heart journal 1995;129(1):98-106.
1994: Lena S Sun; Yvonne Vulliemoz; F Huber; John P Bilezikian; Richard B Robinson
An excitatory muscarinic response in neonatal rat ventricular myocytes and its modulation by sympathetic innervation.
Journal of molecular and cellular cardiology 1994;26(6):779-87.
1994: H S Oz; Huan Huang; Murray Wittner; Herbert B Tanowitz; John P Bilezikian; Stephen A Morris
Evidence for guanosine triphosphate--binding proteins in Trypanosoma cruzi.
The American journal of tropical medicine and hygiene 1994;50(5):620-31.
1994: M J Horwitz; John P Bilezikian
Primary hyperparathyroidism and parathyroid hormone-related protein.
Current opinion in rheumatology 1994;6(3):321-8.
1994: John P Bilezikian
Hypercalcemia.
Current therapy in endocrinology and metabolism 1994;5():511-4.
1993: Stephen A Morris; G Florant; M Saxon; G Chen; John P Bilezikian
Adaptations of myocardial beta-adrenergic receptor complex in hibernating marmots.
The American journal of physiology 1993;265(6 Pt 2):R1430-8.
1993: John P Bilezikian
Clinical review 51: Management of hypercalcemia.
The Journal of clinical endocrinology and metabolism 1993;77(6):1445-9.
1993: J F Tohme; John P Bilezikian
Hypocalcemic emergencies.
Endocrinology and metabolism clinics of North America 1993;22(2):363-75.
1993: John P Bilezikian
Osteoporosis: on the verge of rational effective therapy?
The Mount Sinai journal of medicine, New York 1993;60(2):87-94.
1993: Elizabeth Shane; M C Rivas; Shonni J Silverberg; T S Kim; Ronald B Staron; John P Bilezikian
Osteoporosis after cardiac transplantation.
The American journal of medicine 1993;94(3):257-64.
1993: J Glusman; Stephen A Morris; S Rohde; G Chen; J A Camacho; John P Bilezikian
Opposing influences of dexamethasone and retinoic acid on adenylate cyclase activity in ROS 17/2.8 cells.
Endocrinology 1993;132(1):261-8.
1992: S K Grinspoon; John P Bilezikian
HIV disease and the endocrine system.
The New England journal of medicine 1992;327(19):1360-5.
1992: May Parisien; R W Mellish; Shonni J Silverberg; Elizabeth Shane; Robert Lindsay; John P Bilezikian; David W Dempster
Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1992;7(8):913-9.
1992: H S Oz; Murray Wittner; Herbert B Tanowitz; John P Bilezikian; M Saxon; Stephen A Morris
Trypanosoma cruzi: mechanisms of intracellular calcium homeostasis.
Experimental parasitology 1992;74(4):390-9.
1992: John P Bilezikian
Management of acute hypercalcemia.
The New England journal of medicine 1992;326(18):1196-203.
1992: Yvonne Vulliemoz; F Huber; John P Bilezikian
Regulation of inositol 1,4,5-trisphosphate metabolism by guanine nucleotides in membranes of cultured newborn rat cardiomyocytes.
Biochemical pharmacology 1992;43(5):1001-7.
1992: M J Seibel; F Gartenberg; Shonni J Silverberg; A Ratcliffe; S P Robins; John P Bilezikian
Urinary hydroxypyridinium cross-links of collagen in primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1992;74(3):481-6.
1992: S Ogawa; S Koga; Keisuke Kuwabara; J Brett; B Morrow; Stephen A Morris; John P Bilezikian; Samuel C. Silverstein; David M Stern
Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels.
The American journal of physiology 1992;262(3 Pt 1):C546-54.
1992: Stephen A Morris; Herbert B Tanowitz; M Makman; Victor Hatcher; John P Bilezikian; Murray Wittner
Trypanosoma cruzi: alteration of cAMP metabolism following infection of human endothelial cells.
Experimental parasitology 1992;74(1):69-76.
1991: E M Horn; Peter Danilo; M A Apfelbaum; Mark L Barr; P Pepino; Eric Randall Powers; Craig R Smith; Eric A Rose; John P Bilezikian
Beta-adrenergic receptor sensitivity and guanine nucleotide regulatory proteins in transplanted human hearts and autotransplanted baboons.
Transplantation 1991;52(6):960-6.
1991: Stephen A Morris; E M Horn; T Hawley; D Manning; John P Bilezikian
The influence of detergents on the availability of pertussis toxin substrates.
Archives of biochemistry and biophysics 1991;290(1):86-92.
1991: John P Bilezikian; Shonni J Silverberg; Elizabeth Shane; May Parisien; David W Dempster
Characterization and evaluation of asymptomatic primary hyperparathyroidism.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991;6 Suppl 2():S85-9; discussion S121-4.
1991: Stephen A Morris; S Barr; Louis M Weiss; Herbert B Tanowitz; M Wittner; John P Bilezikian
Myocardial beta-adrenergic adenylate cyclase complex in a canine model of chagasic cardiomyopathy.
Circulation research 1991;69(1):185-95.
1991: D T Coleman; B S Morrow; John P Bilezikian
Effects of guanine nucleotides and parathyroid hormone on inositol 1,4,5-trisphosphate metabolism in canine renal cortical tubular cell membranes.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1991;6(6):599-607.
1991: J F Tohmé; M J Seibel; Shonni J Silverberg; S P Robins; John P Bilezikian
Biochemical markers of bone metabolism.
Zeitschrift für Rheumatologie 1991;50(3):133-41.
1990: Stephen A Morris; Herbert B Tanowitz; M Wittner; John P Bilezikian
Pathophysiological insights into the cardiomyopathy of Chagas' disease.
Circulation 1990;82(6):1900-9.
1990: Shonni J Silverberg; Elizabeth Shane; Thomas P Jacobs; Ethel S Siris; F Gartenberg; D Seldin; Thomas Landes Clemens; John P Bilezikian
Nephrolithiasis and bone involvement in primary hyperparathyroidism.
The American journal of medicine 1990;89(3):327-34.
1990: J F Tohme; John P Bilezikian; Thomas Landes Clemens; Shonni J Silverberg; Elizabeth Shane; Robert Lindsay
Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary hyperparathyroidism.
The Journal of clinical endocrinology and metabolism 1990;70(4):951-6.
1990: May Parisien; Shonni J Silverberg; Elizabeth Shane; L de la Cruz; Robert Lindsay; John P Bilezikian; David W Dempster
The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure.
The Journal of clinical endocrinology and metabolism 1990;70(4):930-8.
1990: May Parisien; Shonni J Silverberg; Elizabeth Shane; David W Dempster; John P Bilezikian
Bone disease in primary hyperparathyroidism.
Endocrinology and metabolism clinics of North America 1990;19(1):19-34.
1990: D T Coleman; John P Bilezikian
Parathyroid hormone stimulates formation of inositol phosphates in a membrane preparation of canine renal cortical tubular cells.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1990;5(3):299-306.
1990: H M Han; John P Bilezikian; Richard B Robinson
Functional uncoupling of the inhibitory alpha 1-adrenergic response from a G-protein in innervated cultured cardiac cells by K+ depolarization.
Journal of molecular and cellular cardiology 1990;22(1):49-56.
1989: H M Han; Richard B Robinson; John P Bilezikian; Susan F Steinberg
Developmental changes in guanine nucleotide regulatory proteins in the rat myocardial alpha 1-adrenergic receptor complex.
Circulation research 1989;65(6):1763-73.
1989: S A Turken; M Cafferty; Shonni J Silverberg; L De La Cruz; C Cimino; Dale J Lange; R E Lovelace; John P Bilezikian
Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism.
The American journal of medicine 1989;87(5):553-7.
1989: Stephen A Morris; John P Bilezikian; Victor Hatcher; Louis M Weiss; Herbert B Tanowitz; M Wittner
Trypanosoma cruzi: infection of cultured human endothelial cells alters inositol phosphate synthesis.
Experimental parasitology 1989;69(4):330-9.
1989: Stephen A Morris; Louis M Weiss; Stephen M Factor; John P Bilezikian; Herbert B Tanowitz; M Wittner
Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice.
Journal of the American College of Cardiology 1989;14(3):782-9.
1989: E M Horn; N J Johnson; John P Bilezikian; Michael R Rosen
Developmental changes in the electrophysiological properties and the beta-adrenergic receptor-effector complex in atrial fibers of the canine coronary sinus.
Circulation research 1989;65(2):325-33.
1989: Felicia Cosman; B Morrow; M Kopal; John P Bilezikian
Stimulation of inositol phosphate formation in ROS 17/2.8 cell membranes by guanine nucleotide, calcium, and parathyroid hormone.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1989;4(3):413-20.
1989: John P Bilezikian
Etiologies and therapy of hypercalcemia.
Endocrinology and metabolism clinics of North America 1989;18(2):389-414.
1989: Shonni J Silverberg; Elizabeth Shane; L de la Cruz; G V Segre; Thomas Landes Clemens; John P Bilezikian
Abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D3 formation in women with osteoporosis.
The New England journal of medicine 1989;320(5):277-81.
1988: John P Bilezikian
Hypercalcemia.
Disease-a-month : DM 1988;34(12):737-99.
1988: E M Horn; S J Corwin; Susan F Steinberg; Y K Chow; G W Neuberg; Paul J Cannon; Eric Randall Powers; John P Bilezikian
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.
Circulation 1988;78(6):1373-9.
1988: John P Bilezikian; Susan F Steinberg; E M Horn; Richard B Robinson; Michael R Rosen
G protein-adrenergic interactions in the heart.
Molecular and cellular biochemistry 1988;82(1-2):5-11.
1988: Stephen A Morris; Herbert B Tanowitz; Victor Hatcher; John P Bilezikian; M Wittner
Alterations in intracellular calcium following infection of human endothelial cells with Trypanosoma cruzi.
Molecular and biochemical parasitology 1988;29(2-3):213-21.
1988: Stephen A Morris; Herbert B Tanowitz; Stephen M Factor; John P Bilezikian; M Wittner
Myocardial adenylate cyclase activity in acute murine Chagas' disease.
Circulation research 1988;62(4):800-10.
1988: Michael R Rosen; Susan F Steinberg; Y K Chow; John P Bilezikian; Peter Danilo
Role of a pertussis toxin-sensitive protein in the modulation of canine Purkinje fiber automaticity.
Circulation research 1988;62(2):315-23.
1987: Stephen A Morris; John P Bilezikian
The influence of EDTA on adenylate cyclase activity in membranes from rat and mouse myocardium.
Biochimica et biophysica acta 1987;931(2):234-41.
1987: Susan F Steinberg; John P Bilezikian; Qais Al-Awqati
Fura-2 fluorescence is localized to mitochondria in endothelial cells.
The American journal of physiology 1987;253(5 Pt 1):C744-7.
1987: Stephen A Morris; John P Bilezikian; Herbert B Tanowitz; M Wittner
Infection of L6E9 myoblasts with Trypanosoma cruzi alters adenylate cyclase activity and guanine nucleotide binding proteins.
Journal of cellular physiology 1987;133(1):64-71.
1987: Ethel S Siris; Thomas Landes Clemens; David W Dempster; Elizabeth Shane; G V Segre; Robert Lindsay; John P Bilezikian
Tumor-induced osteomalacia. Kinetics of calcium, phosphorus, and vitamin D metabolism and characteristics of bone histomorphometry.
The American journal of medicine 1987;82(2):307-12.
1986: Shonni J Silverberg; Elizabeth Shane; Thomas Landes Clemens; David W Dempster; G V Segre; Robert Lindsay; John P Bilezikian
The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjects.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1986;1(4):383-8.
1986: Elizabeth Shane; R C Avioli; V S Greene; M Yeh; J M Owens; Norman H Bell; John P Bilezikian
Enhancement of parathyroid hormone-responsive renal cortical adenylate cyclase activity by a cytosol protein activator from rat reticulocytes.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1986;1(1):41-50.
1985: Elizabeth Shane; M Yeh; A S Feigin; J M Owens; John P Bilezikian
Reticulocyte cytosol activator protein: effects on the stimulatory and inhibitory regulatory proteins of adenylate cyclase.
Endocrinology 1985;117(1):264-70.
1985: Elizabeth Shane; M Yeh; A S Feigin; J M Owens; John P Bilezikian
Cytosol activator protein from rat reticulocytes requires the stimulatory guanine nucleotide-binding protein for its actions on adenylate cyclase.
Endocrinology 1985;117(1):255-63.
1984: Elizabeth Shane; M Yeh; A S Feigin; John P Bilezikian
Reticulocyte cytosol activator protein: its actions upon the beta adrenergic receptor and the N-proteins of adenylate cyclase.
Journal of receptor research 1984;4(1-6):475-86.
1982: Elizabeth Shane; Thomas P Jacobs; Ethel S Siris; S F Steinberg; K Stoddart; Robert E Canfield; John P Bilezikian
Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
The American journal of medicine 1982;72(6):939-44.
1981: Elizabeth Shane; D C Baquiran; John P Bilezikian
Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
Annals of internal medicine 1981;95(1):23-7.
1981: Thomas P Jacobs; Ethel S Siris; John P Bilezikian; D C Baquiran; Elizabeth Shane; Robert E Canfield
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
Annals of internal medicine 1981;94(3):312-6.